HLTW:PA:PA-Multi Units Luxembourg - Lyxor MSCI World Health Care TR UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 508.9

Change

+4.31 (+0.85)%

Market Cap

USD 0.75B

Volume

798.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Sub-Fund is an index-tracking UCITS passively managed. The Reference Currency of the Sub-Fund is the Euro (EUR). The investment objective of sub-fund is to track both the upward and the downward evolution of the MSCI World Health Care Index " Net Total Return (the Index) denominated in US Dollars - while minimising the volatility of the difference between the return of the Sub-Fund and the return of the Index (the "Tracking Error"). The anticipated level of the tracking error under normal market conditions is expected to be up to 0.50%.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.61 (+1.30%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.80 (+0.14%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.07 (+0.02%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.10 (+0.26%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.87 (+1.10%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.10 (+0.02%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.10 (+0.31%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.07 (+0.12%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.16 (-2.18%)

USD 5.25B

ETFs Containing HLTW:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.55% 73% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.55% 73% C 67% D+
Trailing 12 Months  
Capital Gain 6.72% 36% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.72% 34% F 52% F
Trailing 5 Years  
Capital Gain 57.35% 57% F 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.35% 55% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.32% 58% F 64% D
Dividend Return 10.32% 56% F 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.81% 71% C- 85% B
Risk Adjusted Return 117.21% 91% A- 96% N/A
Market Capitalization 0.75B 73% C 75% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike